Diverse Presentation of Secondary Aortoenteric Fistulae

por Simon, Tracey, Feller, Edward
Publicado 2011

Fibrosis Progression and Incidence of Cirrhosis and Hepatic Decompensation in Persons Treated with Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir: Results from ERCHIVES

por Simon, Tracey, Yan, Peng, Kort, Jens, Butt, Adeel
Publicado 2017

Autopsy histology data suggest cirrhosis is frequently under-reported on death certificates

por Hagström, Hannes, Simon, Tracey G., Söderling, Jonas, Ludvigsson, Jonas F.
Publicado 2023

Mortality in Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: Results From A Nationwide Cohort

por Simon, Tracey G., Roelstraete, Bjorn, Khalili, Hamed, Hagström, Hannes, Ludvigsson, Jonas F.
Publicado 2020

Changes in circulating lipids level over time after acquiring HCV infection: results from ERCHIVES

por Butt, Adeel A., Yan, Peng, Simon, Tracey G., Chung, Raymond T., Abou-Samra, Abdul-Badi
Publicado 2015

Nonalcoholic steatohepatitis (NASH) is associated with cardiac remodeling and dysfunction

por Simon, Tracey G., Bamira, Daniel G., Chung, Raymond T., Weiner, Rory B., Corey, Kathleen E.
Publicado 2017

Prescribing Trends of Oral Anticoagulants in US Patients With Cirrhosis and Nonvalvular Atrial Fibrillation

por Simon, Tracey G., Schneeweiss, Sebastian, Singer, Daniel E., Sreedhara, Sushama Kattinakere, Lin, Kueiyu Joshua
Publicado 2023

Model for end‐stage liver disease Na Score predicts incident major cardiovascular events in patients with nonalcoholic fatty liver disease

por Simon, Tracey G., Kartoun, Uri, Zheng, Hui, Chan, Andrew T., Chung, Raymond T., Shaw, Stanley, Corey, Kathleen E.
Publicado 2017

Risk of severe COVID-19 and mortality in patients with established chronic liver disease: a nationwide matched cohort study

por Simon, Tracey G., Hagström, Hannes, Sharma, Rajani, Söderling, Jonas, Roelstraete, Bjorn, Larsson, Emma, Ludvigsson, Jonas F.
Publicado 2021

Development and Validation of a Novel Tool to Predict Model for End-Stage Liver Disease (MELD) Scores in Cirrhosis, Using Administrative Datasets

por Simon, Tracey G, Schneeweiss, Sebastian, Wyss, Richard, Lu, Zhigang, Bessette, Lily G, York, Cassandra, Lin, Kueiyu Joshua
Publicado 2023

The MELD-Plus: A generalizable prediction risk score in cirrhosis

por Kartoun, Uri, Corey, Kathleen E., Simon, Tracey G., Zheng, Hui, Aggarwal, Rahul, Ng, Kenney, Shaw, Stanley Y.
Publicado 2017

Aspirin Use Is Associated with a Reduced Incidence of Hepatocellular Carcinoma: A Systematic Review and Meta‐analysis

por Memel, Zoe N., Arvind, Ashwini, Moninuola, Oluwatoba, Philpotts, Lisa, Chung, Raymond T., Corey, Kathleen E., Simon, Tracey G.
Publicado 2020

Risk of infections and their role on subsequent mortality in biopsy‐proven alcohol‐related liver disease

por Hagström, Hannes, Thiele, Maja, Simon, Tracey G., Sharma, Rajani, Röckert Tjernberg, Anna, Roelstraete, Bjorn, Söderling, Jonas, Ludvigsson, Jonas F.
Publicado 2022

The empirical dietary inflammatory pattern score and the risk of nonalcoholic fatty liver disease and cirrhosis

por Ibrahim, Maryam K., Wilechansky, Robert M., Challa, Prasanna K., Zhang, Xuehong, Giovannucci, Edward, Stampfer, Meir, Chan, Andrew T., Simon, Tracey G.
Publicado 2023

Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden

por Ludvigsson, Jonas F., Axelrad, Jordan, Halfvarson, Jonas, Khalili, Hamed, Larsson, Emma, Lochhead, Paul, Roelstraete, Bjorn, Simon, Tracey G., Söderling, Jonas, Olén, Ola
Publicado 2021

Body weight variability and the risk of cardiovascular outcomes in patients with nonalcoholic fatty liver disease

por Kim, Mi Na, Han, Kyungdo, Yoo, Juhwan, Ha, Yeonjung, Chon, Young Eun, Lee, Ju Ho, Simon, Tracey G., Chan, Andrew T., Hwang, Seong Gyu
Publicado 2021

Risk of Cardiovascular Disease in Individuals With Nonobese Nonalcoholic Fatty Liver Disease

por Arvind, Ashwini, Henson, Jacqueline B., Osganian, Stephanie A., Nath, Cheryl, Steinhagen, Lara M., Memel, Zoe N., Donovan, Arley, Balogun, Oluwafemi, Chung, Raymond T., Simon, Tracey G., Corey, Kathleen E.
Publicado 2021

MON-286 Peak Stimulated Growth Hormone Is Lower in Subjects with Nonalcoholic Fatty Liver Disease Than Controls of Similar Sex, Age and BMI

por Dichtel, Laura E, Haines, Melanie S, Kimball, Allison, Rao, Elizabeth M, Bollinger, Bryan, Gerweck, Anu V, Husseini, Jad, Simon, Tracey G, Corey, Kathleen E, Bredella, Miriam A, Miller, Karen Klahr
Publicado 2020

OR27-2 Growth Hormone Reduces Hepatic Steatosis, Inflammation and Fibrosis in Adults with Overweight/Obesity and Nonalcoholic Fatty Liver Disease

por Bartsch, Lea, Bredella, Miriam, Chicote, Mark L, Colling, Caitlin, Corey, Kathleen, Drescher, Hannah, Haines, Melanie, Husseini, Jad, Kimball, Allison, Lauer, Georg, Long, Michelle, Miller, Karen, Simon, Tracey, Dichtel, Laura
Publicado 2022

Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD

por Balogun, Oluwafemi, Wang, Jeffrey Y., Shaikh, Emad S., Liu, Karine, Stoyanova, Stefania, Memel, Zoe N., Schultz, Hayley, Mun, Lisa, Bertman, Jack, Rogen, Cheryl A., Ibrahim, Maryam K., Berschback, Madeline, Uche-Anya, Eugenia, Wilechansky, Robert, Simon, Tracey G., Corey, Kathleen E.
Publicado 2023